Corrigendum to ‘Design of the Reduction of Events with Darbepoetin Alfa in Heart Failure (RED-HF): A Phase III, Anaemia Correction, Morbidity–Mortality Trial’ [ <i>Eur J Heart Fail</i> 2009;11:795–801]

The authors of this paper regret that a spelling error was introduced to the list of Trial Committees. In the Clinical Endpoint Committee, the name A.C. Pouler was incorrectly spelt. The correct spelling is A.C. Pouleur. The authors wish to apologize for this error.